In conclusion, FMT and anti‐PD‐1 together successfully colonized the gut of responders and altered the microbiota composition, reprogramming the tumor microenvironment to counter anti‐PD‐1 resistance in the PD‐1 advanced melanoma subgroup.96 Here, PDCD1 is linked to neoplasm.